4//SEC Filing
O'Brien Stephanie Monaghan 4
Accession 0001127602-21-000254
CIK 0001492422other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 7:21 PM ET
Size
5.0 KB
Accession
0001127602-21-000254
Insider Transaction Report
Form 4
O'Brien Stephanie Monaghan
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-01-01+27,600→ 27,600 totalExercise: $57.20Exp: 2030-12-31→ Common Stock (27,600 underlying)
Footnotes (1)
- [F1]This option was granted 01/01/2021. The option vests quarterly over 1 year on the last day of each quarter from grant date.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001720907
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 7:21 PM ET
- Size
- 5.0 KB